Cargando…
Asthma and COVID-19: an update
As the world faces the coronavirus disease 2019 (COVID-19) pandemic due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, concerns have been raised that asthma patients could be at increased risk of SARS-CoV-2 infection and disease severity. However, it appears that asthma i...
Autores principales: | Adir, Yochai, Saliba, Walid, Beurnier, Antoine, Humbert, Marc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8674937/ https://www.ncbi.nlm.nih.gov/pubmed/34911694 http://dx.doi.org/10.1183/16000617.0152-2021 |
Ejemplares similares
-
COVID-19 risk and outcomes in adult asthmatic patients treated with biologics or systemic corticosteroids: Nationwide real-world evidence
por: Adir, Yochai, et al.
Publicado: (2021) -
Association between sex and SARS-CoV-2 infection and hospitalisation as a result of COVID-19
por: Adir, Yochai, et al.
Publicado: (2021) -
Asthma and atopy in COVID-19: 2021 updates
por: Carr, Tara F., et al.
Publicado: (2022) -
Inhaled corticosteroids and COVID-19 outcomes in asthma: the Israeli experience
por: Adir, Yochai, et al.
Publicado: (2022) -
Post-acute COVID-19 syndrome
por: Montani, David, et al.
Publicado: (2022)